. Author manuscript; available in PMC: 2014 Dec 1.

Published in final edited form as: Patient. 2013 Dec;6(4):10.1007/s40271-013-0031-2. doi: 10.1007/s40271-013-0031-2

Table III.

Discrete-Choice Experiment studies in IBD

Study	Study Population and Sample Size	Study Aim
Hodgkins P et al.¹³⁸	400 UC patients	To determine preferences for 5-ASA therapy based on self-reported adherence
Johnson FR et al.¹³⁷	315 gastroenterologists 580 CD patients	To measure and compare acceptability of medication risks and benefits between adult CD patients and gastroenterologists
Lichtenstein GR et al.¹³⁴	252 CD patients	To determine treatment preferences for and relative importance of treatment attributes for CD
Johnson FR et al.¹³⁶	345 CD patients > 18 years old 150 parents of CD patients < 18 years old	To measure and compare risk preferences for medical therapy between parents of juvenile patients and adult patients
Johnson FR et al.¹³⁵	580 CD patients	To measure CD patients’ willingness to accept serious adverse events in exchange for medication efficacy